Trial Profile

EXTEND-IA TNK: Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase Part 2

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

06 Mar 2023 Results of pooled post hoc analysis (n=71, EXTEND-IA TNK trials) assessing safety and efficacy of tenecteplase in patients with tandem lesion stroke published in the Neurology
10 Feb 2023 Results assessing the reperfusion efficacy of tenecteplase and alteplase in subgroups based on these characteristics in a pooled analysis of the EXTEND-IA TNK trials, presented at the International Stroke Conference 2023
02 Feb 2023 Results of pooled analysis from EXTEND-IA TNK trials assessing reperfusion efficacy of tenecteplase and alteplase in subgroups based on these characteristics published in the Stroke

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com